Design, synthesis, and biological evaluation of novel γ-carboline ketones as anticancer agents. 2011

Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
College of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou, 310053 Zhejiang, China.

A series of novel γ-carboline ketones were designed, synthesized and evaluated for their cytotoxic activity in vitro against six human cancer cell lines (A549, SGC, HCT116, MCF-7, K562 and K562R). Biological evaluation revealed that almost all of the new compounds displayed moderate to potent cytotoxic activities against the tested cells. Among them, seven of the fourteen new compounds show more potent cytotoxic activities against K562R cell line than that of the positive control, taxol. Primary mechanism research on the most potent compound 6f indicated that it was a potent tubulin polymerization inhibitor, with IC(50) value of 4.3 μM, equivalent to that of CA-4, and arresting cell cycle in G(2)/M phase.

UI MeSH Term Description Entries
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014404 Tubulin A microtubule subunit protein found in large quantities in mammalian brain. It has also been isolated from SPERM FLAGELLUM; CILIA; and other sources. Structurally, the protein is a dimer with a molecular weight of approximately 120,000 and a sedimentation coefficient of 5.8S. It binds to COLCHICINE; VINCRISTINE; and VINBLASTINE. alpha-Tubulin,beta-Tubulin,delta-Tubulin,epsilon-Tubulin,gamma-Tubulin,alpha Tubulin,beta Tubulin,delta Tubulin,epsilon Tubulin,gamma Tubulin
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D055503 Protein Multimerization The assembly of the QUATERNARY PROTEIN STRUCTURE of multimeric proteins (MULTIPROTEIN COMPLEXES) from their composite PROTEIN SUBUNITS. Protein Dimerization,Protein Heteromultimerizaton,Protein Multimer Assembly,Protein Trimerization,Assembly, Protein Multimer,Dimerization, Protein,Heteromultimerizaton, Protein,Heteromultimerizatons, Protein,Multimer Assembly, Protein,Multimerization, Protein,Trimerization, Protein
D020836 Protein Structure, Quaternary The characteristic 3-dimensional shape and arrangement of multimeric proteins (aggregates of more than one polypeptide chain). Quaternary Protein Structure,Protein Structures, Quaternary,Quaternary Protein Structures

Related Publications

Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
June 2023, Molecules (Basel, Switzerland),
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
September 2015, Bioorganic & medicinal chemistry letters,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
January 2008, Journal of medicinal chemistry,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
January 2015, European journal of medicinal chemistry,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
May 2018, RSC advances,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
April 2015, European journal of medicinal chemistry,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
June 2021, Bioorganic chemistry,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
March 2024, Chemical biology & drug design,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
June 2014, European journal of medicinal chemistry,
Jing Chen, and Tao Liu, and Rui Wu, and Jianshu Lou, and Xiaowu Dong, and Qiaojun He, and Bo Yang, and Yongzhou Hu
January 2022, Molecules (Basel, Switzerland),
Copied contents to your clipboard!